Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: pharmaceutical technology

August 9, 2024 Events

15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

15th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology will be held in Prague, Czech Republic, March 23 – 26, 2026.

Continue reading

November 20, 2020 Events

Innovation of Nanomaterials Based on Cyclodextrins – A symposium at PacifiChem 2021-rescheduled to December 16 – 21, 2021

The 2020 International Chemical Congress of Pacific Basin Societies (PAC CHEM™) was reschyeduled due to the pandemic and will take

Continue reading

October 12, 2020 CD derivatives / E-ducation / Non-pharma applications / Pharma applications

New book: The History of Cyclodextrins

This book edited by Crini, G., Fourmentin, S. and Lichtfouse, E. will be published on November 2 2020, but is available on

Continue reading

March 10, 2020 Drug delivery / Events / Pharma applications

Postponed to 2021: 12th World Meeting on Pharmaceutics, Biopharmaceutics & Pharmaceutical Technology

Due to the spreading of the corona-virus the 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (which was initially

Continue reading

February 28, 2020 Events

Innovation of Nanomaterials Based on Cyclodextrins – A symposium at PacifiChem 2020

The 2020 International Chemical Congress of Pacific Basin Societies (PAC CHEM™), will take place in Honolulu, Hawaii, USA, December 15-20, 2020.

Continue reading

November 9, 2019 Drug delivery / Events / Pharma applications

12th World Meeting on Pharmaceutics, Biopharmaceutics & Pharmaceutical Technology

12th World Meeting on Pharmaceutics, Biopharmaceutics & Pharmaceutical Technology will be held on 23 to 26 March 2020 in Vienna,

Continue reading

Recent Posts

  • Special Issue titled “Cyclodextrins: Properties and Applications, 4th Edition”
  • Cyclodextrins hit the golf course seven years ago — and they are still there
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • Reducing Cholesterol with β-CDP: Insights for NPC and AD

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (355)
  • CD derivatives (431)
  • Cosmetics and toilettry (54)
  • Diagnosis (15)
  • Drug delivery (816)
  • E-ducation (63)
  • Environmental (143)
  • Events (239)
  • Food (233)
  • Gene delivery (22)
  • Household products (6)
  • In Hungarian (4)
  • Life sciences (45)
  • Non-pharma applications (416)
  • Other industrial use (112)
  • Pharma applications (1,219)
  • Supramolecular systems (44)
  • Uncategorized (167)

Top Posts

  • Special Issue titled "Cyclodextrins: Properties and Applications, 4th Edition"
  • Cyclarity Unveils First-Ever Clinical Data Demonstrating Excretion of Oxidized Cholesterol, at American Heart Association Vascular Discovery Scientific Sessions
  • REVTORPYK™: A New FDA Approval for Gedatolisib/HPBCD composition
  • 22nd International Cyclodextrin Symposium (ICS-22) in India
  • Enhancing Curcumin Efficacy Against Triple-Negative Breast Cancer
  • Cyclodextrin-assisted drug delivery to Central Nervous System: Mavenclad™ for multiple sclerosis treatment
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrins and derivatives in drug delivery: New developments, relevant clinical trials, and advanced products
  • Smart Materials and Surfaces - SMS 2026 International Conference
  • Amgen Submits Supplemental New Drug Application For KYPROLIS® (carfilzomib)

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...